← Open Payments lookup

NATALIE BABOLA: Open Payments

NPI 1295344083 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$664 in 16 payments from 7 companies in 2025. Trend: 2023 $150 · 2024 $303 · 2025 $664

Food & beverage: $664
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.2$149
BridgeBio Pharma, Inc.2$139
United Therapeutics Corporation3$115
Medtronic, Inc.2$112
E.R. Squibb & Sons, L.L.C.5$92
American Regent1$34
PFIZER INC.1$23

Products named: Attruby, REMODULIN, ELIQUIS, CAMZYOS, INJECTAFER, Orenitram, JARDIANCE, VYNDAQEL.

Industry payments across MD — which companies pay providers there.